DUK vs FGEN · P/E 19, rev $31.74B vs rev $29.6M
Duke Energy Corporation (DUK) versus FibroGen Inc (FGEN) — a side-by-side from cached financials, not a winner call.
Duke Energy Corporation (DUK) is a utilities - regulated electric company listed on NYSE.
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
Latest reported DUK revenue for 2025-12-31 was $31.74B. Net income was $4.97B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
DUK currently screens at market cap $96.46B and trailing P/E 19.0. FGEN currently screens at market cap $39.3M.
Not investment advice. Open the DUK and FGEN stock pages for the full models.
Not investment advice.